HOME >> BIOLOGY >> NEWS
Tree rings show elevated tungsten coincides with Nevada leukemia cluster

e causes for the leukemia cases in Fallon (http://www.atsdr.cdc.gov/HAC/PHA/fallonair/finalair.pdf), tungsten was mentioned as "a contaminant of concern because it was elevated in urine samples" collected from Fallon-area residents as part of the investigation.

Previous research by Sheppard and his colleagues found elevated levels of tungsten and cobalt in airborne and surface dust and in lichens in Fallon.

The researchers also analyzed airborne tungsten particles from Fallon to determine their source. The analysis found that the particles "were anthropogenic in origin, not natural." The particles were relatively uniform in size, ranging from about 1.0 to 5.9 micrometers in diameter.

Particles less than 10 micrometers in diameter are small enough to be inhaled and have potential to cause health problems, according to the U.S. Environmental Protection Agency. (http://www.epa.gov/air/particlepollution/)

The research team's study on the characteristics of the tungsten particles has been accepted for publication by the journal Microscopy and Microanalysis.

Fallon is a community of about 8,000 located in Churchill County about 60 miles east of Reno, Nev. Tungsten is naturally present in soils and rocks in Churchill County and other parts of Nevada.

The metal was mined in the region around Fallon at various sites, including Churchill Butte. Tungsten, tungsten steels and tungsten carbide are used in hardened tools and tools exposed to high temperatures, such as drill bits and the filaments of incandescent light bulbs.

The increase in Fallon's childhood leukemia began around 1997. Heavy metals had been suggested as one possible environmental cause of cancers, so Ridenour and Witten began investigating how to conduct research on Fallon's environment.

Witten approac
'"/>

Contact: Mari N. Jensen
mnjensen@email.arizona.edu
520-626-9635
University of Arizona
30-Apr-2007


Page: 1 2 3 4

Related biology news :

1. MIT study: Maturity brings richer memories
2. Variant CJD -- Prion amplification breakthrough brings new insights and hopes for a blood test
3. Extracting eggs from pre-pubertal cancer patients brings hope for future fertility
4. Homing pigeons get their bearings from their beaks
5. Gold nanorods assemble themselves into rings
6. Dilbert of academia brings humor to talk at UH
7. Disorderly protein brings order to cell division
8. From hot springs to rice farms, scientists reveal new insights into the secret lives of archaea
9. $1 million Myers Fellowship brings US research techniques to Melbourne
10. Flying in tune: Buzz brings mosquito pairs together
11. Watching rocks grow: Theory explains landscape of geothermal springs

Post Your Comments:
(Date:12/10/2014)... California , December 9, 2014 ... with ITN,s BCARD Platform   ... cloud-based enterprise meeting scheduling solutions for business-to-business (B2B) ... the world leader in mobile near-field communication (NFC), ...      (Logo: http://photos.prnewswire.com/prnh/20140612/691055) , ...
(Date:12/4/2014)... Dec. 3, 2014  Crossmatch™, a leading provider ... its DigitalPersona ® Pro Enterprise software and ... deployed throughout First Bank branch locations in ... Carolina and Virginia. First Bank, a progressive ... Pines, North Carolina , selected the Crossmatch ...
(Date:11/21/2014)... -- According to a new market research ... Access Control, Intrusion Detection, Parking Management, Under Vehicle Inspection), ... Geography - Global Forecasts to 2020", published by MarketsandMarkets, ... around $25 Billion in 2014 and is expected to ... of 8.69%. Browse 116 market data Tables ...
Breaking Biology News(10 mins):Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 3First Bank Partners with Crossmatch to Increase Log In Security 2First Bank Partners with Crossmatch to Increase Log In Security 3Industrial Security Systems Market Worth $38 Billion by 2020 2Industrial Security Systems Market Worth $38 Billion by 2020 3
(Date:12/19/2014)... -- Decision Resources Group finds that the Asia ... through 2023 as the aging population, increasing adoption of ... all spur procedure volumes. Growth will be particularly rapid ... and India , where rising ... a larger proportion of the population. Other ...
(Date:12/17/2014)... NY (PRWEB) December 16, 2014 The ... changes since 2013, which is why IBISWorld updated its ... industry continues to benefit from an intensified focus on ... proposal for new emission standards for power plants and ... operators. According to IBISWorld Industry Analyst Sarah Kahn, “a ...
(Date:12/17/2014)... 17, 2014 Ipsen Biopharmaceuticals, Inc., ... ADR: IPSEY), today announced that Somatuline® ... Somatuline®) was approved by the U.S. Food and ... neuroendocrine tumors (GEP-NETs) in adult patients with unresectable, ... disease to improve progression-free survival (PFS). , “The ...
(Date:12/17/2014)... (PRWEB) December 17, 2014 Gene ... that it has entered into a technology access ... (ADM) to apply DNA2.0’s proprietary protein engineering technology, ... process. , “We are extremely excited that the ... platform. This proprietary bioengineering technology has now ...
Breaking Biology Technology:Asia Pacific Dental Biomaterial Market Will Grow Strongly Through 2023 2Asia Pacific Dental Biomaterial Market Will Grow Strongly Through 2023 3Activated Carbon Manufacturing in the US Industry Market Research Report Has Been Updated from IBISWorld 2Activated Carbon Manufacturing in the US Industry Market Research Report Has Been Updated from IBISWorld 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2
Cached News: